- Home
- MLP vs THRD Comparison
MLP vs THRD Comparison
Compare MLP & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- THRD
- Stock Information
- Founded
- MLP 1909
- THRD 2019
- Country
- MLP United States
- THRD United States
- Employees
- MLP N/A
- THRD N/A
- Industry
- MLP Real Estate
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- MLP Finance
- THRD Health Care
- Exchange
- MLP Nasdaq
- THRD Nasdaq
- Market Cap
- MLP 512.1M
- THRD 512.9M
- IPO Year
- MLP 1972
- THRD 2022
- Fundamental
- Price
- MLP $24.75
- THRD $13.93
- Analyst Decision
- MLP
- THRD Strong Buy
- Analyst Count
- MLP 0
- THRD 3
- Target Price
- MLP N/A
- THRD $20.33
- AVG Volume (30 Days)
- MLP 16.1K
- THRD 184.1K
- Earning Date
- MLP 11-15-2024
- THRD 11-07-2024
- Dividend Yield
- MLP N/A
- THRD N/A
- EPS Growth
- MLP N/A
- THRD N/A
- EPS
- MLP N/A
- THRD N/A
- Revenue
- MLP $11,273,000.00
- THRD N/A
- Revenue This Year
- MLP N/A
- THRD N/A
- Revenue Next Year
- MLP N/A
- THRD N/A
- P/E Ratio
- MLP N/A
- THRD N/A
- Revenue Growth
- MLP 18.71
- THRD N/A
- 52 Week Low
- MLP $13.76
- THRD $5.82
- 52 Week High
- MLP $26.46
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- MLP 68.49
- THRD 54.76
- Support Level
- MLP $21.29
- THRD $11.69
- Resistance Level
- MLP $22.70
- THRD $14.64
- Average True Range (ATR)
- MLP 1.08
- THRD 0.99
- MACD
- MLP 0.23
- THRD -0.04
- Stochastic Oscillator
- MLP 95.35
- THRD 67.67
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.